Miguel, a 63-year-old Los Angeles teacher, recently marked the 38th anniversary of his diagnosis with HIV. The doctor had told him he would be dead in a couple of years. He lived fearful that each ...
Rukobia (fostemsavir) is a prescription drug that’s used to treat HIV in certain situations. Rukobia comes as an extended-release oral tablet. Rukobia is used along with other drugs to treat HIV-1 in ...
Doctors at DAP Health have begun administering a new twice-a-year injectable HIV prevention medication, which was approved by the Food and Drug Administration in June. Gilead's drug lenacapavir ...
SEATTLE (Reuters) - Full details from a pivotal trial of Gilead Sciences Inc experimental Quad HIV pill show that it caused fewer adverse side effects than the company's current three-drug pill, ...
Medically reviewed by Renita White, MDFact checked by Nick BlackmerMedically reviewed by Renita White, MDFact checked by Nick Blackmer Human immunodeficiency virus (HIV) is a virus that causes disease ...
A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug Administration to be used to prevent HIV. Gilead Sciences, maker of the drug, ...
Journavx (suzetrigine) can cause side effects ranging from mild to serious. More common side effects include muscle spasms and itchiness. If side effects from Journavx become difficult to tolerate, ...
The Food and Drug Administration (FDA) recently approved lenacapavir for HIV prevention in both men and women. Many experts believe this twice a year treatment could be a game changer in the fight ...
A generation has passed since the world saw the peak in AIDS-related deaths. Those deaths — agonizing, from diseases or infections the body might otherwise fight off — sent loved ones into the streets ...
The scope of FDA warnings about compounded drugs is narrower than messaging suggests, because they do not center on the ...
Med Safety, a free smartphone app, has boosted healthcare workers’ reporting of adverse drug reactions in Uganda. Thank you for reading Nation.Africa Show plans A simple mobile app is transforming how ...